Litcius/Paper detail

FDA approves AstraZeneca’s anifrolumab for lupus

Asher Mullard

2021Nature Reviews Drug Discovery21 citationsDOI

Topics & Concepts

MedicineSystemic lupus erythematosusInvestigational DrugsPharmacologyDermatologyInternal medicineClinical trialDiseaseEicosanoids and Hypertension PharmacologyScience, Research, and MedicinePharmacogenetics and Drug Metabolism
FDA approves AstraZeneca’s anifrolumab for lupus | Litcius